Pure Global

"Sumitomo" proton therapy system - Taiwan Registration a81cded34565851a3332fcd66a4abc00

Access comprehensive regulatory information for "Sumitomo" proton therapy system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a81cded34565851a3332fcd66a4abc00 and manufactured by Sumitomo Heavy Industries, Ltd. Ehime works-Nihama Factory. The authorized representative in Taiwan is SHI Industrial Equipment (Taiwan) Co., Ltd..

This page provides complete technical specifications, regulatory compliance details, 2 companies making similar products including Sumitomo Heavy Industries, Ltd. Ehime works-Nihama Factory, Sumitomo Heavy Industries, Ltd. Ehime works-Niihama Factory, and 5 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
2 Competitors
5 Recent Registrations
a81cded34565851a3332fcd66a4abc00
Registration Details
Taiwan FDA Registration: a81cded34565851a3332fcd66a4abc00
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Sumitomo" proton therapy system
TW: โ€œไฝๅ‹โ€่ณชๅญๆฒป็™‚็ณป็ตฑ
Risk Class 2

Registration Details

a81cded34565851a3332fcd66a4abc00

DHAS5603379405

Product Details

For details, it is Chinese approved copy of the imitation order

P Radiology Science

P.5050 Medical Charged Particle Radiotherapy System

Input;; The use of this device shall comply with the provisions of the "Administrative Measures for the Implementation or Use of Medical Devices for Specific Medical Technology Inspection and Testing". Consent letter must be attached to the import (consent from the Atomic Energy Commission must be obtained for each import)

Dates and Status

Jul 16, 2020

Jul 16, 2025